LDL cholesterol, the LDL receptor pathway & PCSK9Sep. 10, 2016
A mechanism of action animation on the potential role of the inhibition of PCSK9 with a monoclonal antibody.
Provided as an educational service by Regeneron /Sanofi
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.